Komori
Other Disclosures3762TECHMATRIX CORPORATIONInformation and Communications, Services and Others

PSP adds “SwiftMR” to its AI platform for image diagnosis support

PSP will add SwiftMR, an MRI image reconstruction software provided by AIRS Medical Japan LLC, to the AI platform for diagnostic imaging support it operates with エムスリーAI株式会社, and begin offering the software.

Worth reading
63In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Announced details

AI platform for diagnostic imaging supportSwiftMR (Swift M-R)NOBORI CUBE
Applicable field (uses covered by this announcement)

MRI examinations at healthcare institutions, diagnostic imaging support, and operational efficiency in clinical settings

Launch date17 September 2026 (start)
What the company reported numerically
Usage history

SwiftMR from AIRS Medical Inc. has been deployed at more than 1,900 healthcare institutions in over 50 countries worldwide and has been used in more than 12 million examinations (cumulative).

Relationship between the counterparty and the company
TECHMATRIX CORPORATION3762
Relationship with the Company

PSP株式会社 is a consolidated subsidiary of TECHMATRIX CORPORATION, with a 50.02% ownership interest. PSP operates a business providing an AI platform for diagnostic imaging support with エムスリーAI株式会社, while AIRS Medical Japan provides SwiftMR.

CounterpartyエムスリーAI株式会社AIRS Medical Japan LLCAIRS Medical Inc.

エムスリーAI株式会社 is based in Minato-ku, Tokyo, and its representative director and president is Sugihara Kenichi (杉原賢一). The company provides a platform that enables healthcare institutions to use medical AI. AIRS Medical Japan LLC is based in Minato-ku, Tokyo, and its representative is Lee Seung-hwan. It is the Japanese subsidiary of AIRS Medical Inc., headquartered in Seoul, South Korea. AIRS Medical Inc. was established in 2018 as a startup originating at Seoul National University and operates in more than 50 countries worldwide.

Registration number and expiry date

Medical device certification number: 305AHBZI00041000. The JMDN generic name code is 40940012. Expiration date: Not disclosed.

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Announced details
ItemDetails
Names of Products / Services CoveredAI platform for diagnostic imaging support, SwiftMR (Swift M-R), NOBORI CUBE
CounterpartyエムスリーAI株式会社, AIRS Medical Japan LLC, AIRS Medical Inc.
Counterparty overviewエムスリーAI株式会社 is based in Minato-ku, Tokyo, and its representative director and president is Sugihara Kenichi (杉原賢一). The company provides a platform that enables healthcare institutions to use medical AI. AIRS Medical Japan LLC is based in Minato-ku, Tokyo, and its representative is Lee Seung-hwan. It is the Japanese subsidiary of AIRS Medical Inc., headquartered in Seoul, South Korea. AIRS Medical Inc. was established in 2018 as a startup originating at Seoul National University and operates in more than 50 countries worldwide.
Relationship with the CompanyPSP株式会社 is a consolidated subsidiary of TECHMATRIX CORPORATION, with a 50.02% ownership interest. PSP operates a business providing an AI platform for diagnostic imaging support with エムスリーAI株式会社, while AIRS Medical Japan provides SwiftMR.
Launch date17 September 2026 (start)
Applicable areaMRI examinations at healthcare institutions, diagnostic imaging support, and operational efficiency in clinical settings
Registration number and expiry dateMedical device certification number: 305AHBZI00041000. The JMDN generic name code is 40940012. Expiration date: Not disclosed.
Usage historySwiftMR from AIRS Medical Inc. has been deployed at more than 1,900 healthcare institutions in over 50 countries worldwide and has been used in more than 12 million examinations (cumulative).
Items this document does not state (10)
Contract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyLocationLocation scaleQuantitative EffectsImpact on Business PerformanceSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To help shorten MRI scan times while maintaining image quality through AI-based noise reduction and image reconstruction, thereby improving the efficiency of MRI examinations and the quality of care provided in clinical settings.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
PSP adds “SwiftMR” to its AI platform for image diagnosis support | TECHMATRIX CORPORATION (3762) timely disclosure | Komori